| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |